Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure
Gregg C. Fonarow, MD, FACC*,*,
William F. Peacock, MD ,
Christopher O. Phillips, MD, MPH ,
Michael M. Givertz, MD, FACC ,
Margarita Lopatin, MS|| for the ADHERE Scientific Advisory Committee and Investigators
* Ahmanson–UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California
Department of Emergency Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Medicine, Brigham & Women’s Hospital, Boston, Massachusetts
|| Department of Biostatistics, Scios Inc., Mountain View, California.
View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Relationship Between BNP Quartiles and In-Hospital Mortality
In-hospital mortality rates by B-type natriuretic peptide (BNP) quartiles (Q) (unadjusted) in the entire patient cohort (A), in patients with left ventricular ejection fraction (LVEF) <40% (n = 19,544) (B), in patients with LVEF  40% (n = 18,164) (C), and in patients with LVEF 50% (n = 12,631) (D). Each among-group comparison p < 0.0001.
|
|
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Scatterplot Smoother of BNP Levels and In-Hospital Mortality
Local regression scatterplot smoother (loess) of B-type natriuretic peptide (BNP) levels and in-hospital mortality risk. The vertical marks on the loess line indicate density of the data.
|
|
|
